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Hypercholesterolemia is a well-known etiological factor for cardiovascular disease and a common symptom of most types of
metabolic disorders. Camellia japonica is a traditional garden plant, and its flower and seed have been used as a base oil of
traditional cosmetics in East Asia. The present study was carried out to evaluate the effect of C. japonica fruit extracts (CJF) in
a high fat diet- (HFD-) induced hypercholesterolemic rat model. CJF was administered orally at three different doses: 100, 400,
and 800mg⋅kg−1⋅day−1 (CJF 100, 400, and 800, resp.). Our results showed that CJF possessed strong cholesterol-lowering potency
as indicated by the decrease in serum total cholesterol (TC), triglyceride (TG), and low-density lipoprotein (LDL), accompanied
by an increase in serum high-density lipoprotein (HDL). Furthermore, CJF reduced serum lipid peroxidation by suppressing the
formation of thiobarbituric acid reactive substance. In addition, oil red O (ORO) staining of rat arteries showed decreased lipid-
positive staining in the CJF-treated groups compared to the control HFD group. Taken together, these results suggest that CJF could
be a potent herbal therapeutic option and source of a functional food for the prevention and treatment of atherosclerosis and other
diseases associated with hypercholesterolemia.
1. Introduction
A high blood level of cholesterol, known as hypercholes-
terolemia, accelerates the oxidation of serum lipids and is
known to contribute to the disruption of the circulatory
systems homeostasis by a variety of chemical and physical
processes. Hypercholesterolemia is generated by multiple
factors such as unhealthy dietary practices, obesity, genetic
disposition, and insufficient daily exercise. Previous studies
have already highlighted the prevalence of hypercholes-
terolemia that could ultimately affect the majority of the
adult population of developed countries [1]. Particularly, high
blood level of low-density lipoprotein (LDL, >100mg/dL)
cholesterol is considered crucial to the pathogenesis of car-
diovascular disorders (CVDs) that can lead to various disease
states including atherosclerosis progression and ischemic
stroke [2]. In addition, a reduced blood level of high-density
lipoprotein (HDL, <40mg/dL) cholesterol is also a critical
risk factor of hypercholesterolemia-related CVDs [3]. Several
studies have demonstrated that high fat or high-calorie diets
can induce obesity and hyperlipidemia in the normal rodent
model [4, 5].
Furthermore, various clinical studies have shown strong
correlations between elevated circulating triglyceride (TG),
total cholesterol (TC), and reduced HDL levels as major
predictors of obesity, diabetes, and hyperlipidemia [6, 7].The
oxidation of serum lipids by oxidative/nitrative stress in the
circulatory system accelerates the esterification of cholesterol
and endothelium dysfunction [8]. Research evidence has
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revealed the increased generation of superoxide by nicoti-
namide adenine dinucleotide phosphate (NADPH) oxidase
(NOX) activity in the hearts of cholesterol-fedWistar rats [9].
Moreover, the cardiac expressions of antioxidant enzymes are
decreased in hypercholesterolemia rats [10]. In this instance,
lipid peroxidation plays a key role in vascular inflammation
and leads to endothelial injury, development of atherosclero-
sis, and hypertension [11, 12]. Hence, the reduction of serum
LDL while increasing HDL levels in blood might be a critical
therapeutic target to control hyperlipidemia and obesity.
Camellia japonica is a popular ornamental plant that
usually appears as a colony in wild environmental conditions.
Geographically, it is mainly distributed in East Asia and
China [13]. A previous study revealed that extracts of different
parts of C. japonica have various biological activities such
as antihuman immunodeficiency virus (HIV) activity [14],
antioxidant [15], antiphotoaging [16], and hypotriglyceri-
demic effects [17]. However, studies on these biological
activities have been focused on the seeds, flowers, and leaves,
not the fruits. Our previous in vitro and ex vivo data suggested
that the ethanol extract of C. japonica fruit (CJF) showed
beneficial effects on the cardiovascular system [18]. These
effects include contributing to the improvement of vascular
tone by releasing nitric oxide (NO) in endothelial cells and
inhibiting smooth muscle cell proliferation and migration
[18].
However, the biological effects of CJF on the cardiovascu-
lar physiology are still unclear. Hyperlipidemia and obesity
are known as the main causes of atherogenesis [19, 20].
Therefore, the aim of this study is to elucidate the effects of
CJF on the serum lipid composition using a HFD-induced
hypercholesterolemic Wistar rat model. This animal model
could provide the optimum physiological conditions for
evaluating the effect of CJF in hyperlipidemia and obesity.
We demonstrated the effect of CJF on the serum lipid
profile including the LDL, HDL, TG, and TC, as well as
its inhibition of serum lipid peroxidation including lipid
accumulation in the inner layer of the arteries. The results of
this study along with our previous results provide evidence
to support the feasibility of developing CJF as a potential
therapeutic option for the treatment of atherosclerosis as well
as hypercholesterolemia-associated CVDs.
2. Materials and Methods
2.1. Plant Extracts. The different C. japonica plant parts used
in this study were collected from the southern parts of the
Korean Peninsula, and a voucher specimen was deposited at
the Herbarium of the Jeonnam Forest Resources Research
Institute, Korea. The C. japonica fruit extract (CJF) was
prepared as previously described [18]. Briefly, 1 kg of the dried
fruit of C. japonica was extracted twice with 70% ethanol for
4 h, and then this crude extract was dried by using a rotatory
evaporator under vacuum to obtain the final extract at a yield
of 93.4 g (9.34%, w/w). For daily administration of CJF during
the experimental period, various doses were freshly prepared
with sterile water.
Table 1: Formula of diet.
Ingredient Normal diet High fat diet
gm Kcal gm Kcal
Casein 80 mesh 200 800 200 800
L-Cystine 3 12 3 12
Corn starch 315 1260 0 0
Maltodextrin 10 35 140 125 500
Sucrose 350 1400 68.8 275.2
Cellulose, BW200 50 0 50 0
Soybean oil 25 225 25 225
Lard 20 180 245 2205
Mineral Mix S10026 10 0 10 0
Dicalcium phosphate 13 0 13 0
Calcium carbonate 5.5 0 5.5 0
Potassium citrate, 1 H
2
O 16.5 0 16.5 0
Vitamin Mix V10001 10 40 10 40
Choline bitartrate 2 0 2 0
FC&C yellow dye #5 0.05 0 — —
FC&C blue dye #1 — — 0.05 0
Total 1055.05 4057 773.85 4057
The amount of each ingredient in gram (gm) and corresponding energy value
in kilocalorie (Kcal) for normal diet (D12450B) and high fat diet (D12492).
2.2. Animals and Oral Extract Administration. All the exper-
imental procedures were conducted in accordance with the
animal care guidelines and were approved by the relevant
Committee of the Mokpo National University. Male Wistar
rats (6-week-old) were purchased from Orient Bio (Seoul,
Korea) and were acclimatized for 1 week with free access
to water and standard rodent chow under a 12 h light-dark
cycle. Then, the rats were divided into five groups (𝑛 = 8).
The normal and control groups were fed a normal and 60%
HFD diet (D12450B and D12492, Research Diet, Inc., USA),
respectively, while the CJF 100, CJF 400, and CJF 800 groups
were given 100, 400, and 800mg⋅kg−1⋅day−1, respectively, in
a HFD for 1 month. The formula with the diet ingredients
and their energy values are shown in Tables 1 and 2.The food
consumption of the rats was measured daily. The rats were
housed two per cage; an equal quantity of the appropriate diet
was weighed (normal and HFD) and placed in the cages of
the respective groups. After 24 h, the weight of the remaining
diet in each cage was measured. On the day of euthanasia,
the rats were anesthetized with ethyl ether, and the blood was
collected via an abdominal artery, followed by centrifugation
to obtain the serum for the lipid profile analysis. The rat
organs were perfused with warm phosphate-buffered saline
(PBS); the arteries were isolated and then fixed with 10%
formalin for the oil red O (ORO) staining assay.
2.3. Measurement of TC, TG, HDL, and LDL. The rat serum
TC and TG levels were analyzed by using enzyme-linked
immunosorbent assay (ELISA) kits (Asan Pharmaceutical
Company, Seoul, Korea) according to the manufacturer’s
protocol. Briefly, 20𝜇L of each of the serum samples and
the cholesterol and TG standard solutions was separately
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Table 2: Energy source in diet.
Normal diet High fat diet
gm % Kcal % gm % Kcal %
Protein 19.2 20 26.2 20
Carbohydrate 67.3 70 26.3 20
Fat 4.3 10 34.9 60
Total (Kcal/gm) 3.85 100 5.24 100
The percentage of calorie of normal diet (D12450B) and high fat diet
(D12492) derived from protein, carbohydrate, and fat in terms of gm% and
Kcal%.
mixed with 3mL of the freshly prepared enzyme solution.
The rat serum HDL level was also analyzed by using an
ELISA kit according to the manufacturer’s protocol (Asan
Pharmaceutical Company, Seoul, Korea). Briefly, 300 𝜇L of
each of the serum and separating solution was mixed and
centrifuged at 3000 rpm for 10min, and then 100 𝜇L of each
of the supernatant and the HDL standard solution was mixed
with 3mL of enzyme solution.Then, the absorbance values of
all the resultant colored products from the TC, TG, and HDL
assays were measured within 1 h using the Epoch microplate
spectrophotometer at a wavelength of 500 nm. The serum
LDL level was calculated according to the Friedewald formula
[21].
2.4. Serum Lipid Peroxidation. The serum lipid peroxidation
wasmeasured by using the thiobarbituric acid (TBA) reactive
substance (TBARS) assay. First, 0.3mL of each of the rat
serum samples from each group was incubated with 50 𝜇L
of 10 𝜇M copper sulfate (CuSO
4
) and 0.6mL phosphate-
buffered saline (PBS) for 4 h at 37∘C. Then, 0.3mL of this
mixture wasmixed with 1 and 3mL of freshly prepared 0.67%
TBA and 0.05N hydrochloric acid (HCl), respectively. The
resulting mixture was heated in boiling water for 30min, and
then the test tubes were collected and placed on ice for 5min
to stop the reaction. After cooling, the resulting chromogen
was extracted with 4mL of a mixture of 85% butanol and 15%
methanol.The organic phase was separated by centrifugation
at 3000 rpm for 10min, and the absorbance was recorded at
a wavelength of 540 nm using the Epoch microplate spec-
trophotometer. A freshly prepared malondialdehyde (MDA)
solution by the hydrolysis of 1,1,3,3,-tetraethoxypropane was
used as the standard.The concentration of serumTBARSwas
calculated by comparing with the standard curve obtained by
serial dilutions of MDA [22]
TBARS (𝜇M) =




where 𝐴control and 𝐴 sample are the absorbance values of the
control (standards) and serum samples, respectively.
2.5. ORO Staining. TheORO stainingwas carried out accord-
ing to the protocol described by Maganto-Garcia et al. [23].
Briefly, the arteries were fixed in 5mL of 10%neutral-buffered
formalin solution overnight on a shaker at 4∘C and washed
overnight in PBS on a shaker at 4∘C. The arteries were
dehydrated at room temperature in a tube containing 5mL
propylene glycol for 2min and then transferred to another
tube containing 5mL of 0.5% ORO for 2 to 4 h at 25∘C.
Then, they were washed sequentially with 85% propylene
glycol in a series of three to four dishes and then further
washed overnight in 5mLPBS on a shaker at 4∘C.The arteries
were subsequently cut lengthwise (vertical) to expose the
inner surface, fixed on silicon elastomer plates in 60mm
dishes using a syringe needle, and kept covered in PBS during
the entire procedure and subsequent storage. The dish was
drained, and 5mL propylene glycol was added for 2min to
dehydrate the tissue samples at room temperature, followed
by incubation with 5mL 0.5% ORO for 2 to 4 hours at 25∘C.
The ORO stain was developed by washing the tissue samples
with 85% propylene glycol in a series of three to four dishes.
Then, the arteries were washed twice with 5mL PBS and
incubated overnight in PBS on a shaker at 4∘C. A scale bar
was added to show the 20mm segments pinned next to the
artery, and, finally, digital photographs of the stained arteries
were taken.
2.6. Statistical Analysis. The statistical package for the social
sciences (SPSS) software (SPSS, Chicago, IL, USA) was used
to perform the data analysis. All data were presented mean
± standard error (SE). The groups were compared by using a
one-way analysis of variance (ANOVA) followed by Duncan’s
post hoc test of multiple comparisons while 𝑃 values ≤ 0.05
were considered statistically significant.
3. Results
3.1. Effect of CJF on BodyWeight, Diet Consumption, and Liver
Weight. Table 3 illustrates the effects of CJF on body weight,
diet intake, and liver weight. Compared to the HFD-fed
control rats, the CJF 400 and 800 groups showed a significant
decrease in the final body weight. The diet consumption rate
was comparable for all the groups. Although the liver weight
was slightly decreased in the CJF 800 group compared to
the HFD-treated group, the difference was not statistically
significant.
3.2. Effect of CJF on Serum TC, TG, HDL, and LDL Levels.
Table 4 shows the effect of CJF on the serum lipid profile of
Wistar rats. Compared to the HFD group, the CJF 800 group
showed a significant 2.4- and 2.3-fold decrease in TC and TG,
respectively, while the HDL level increased significantly 1.8-
fold. In addition, the serum LDL level was increased almost
10-fold in the HFD group compared to the normal diet group
while CJF treatment decreased the serum LDL levels in a
dose-dependent manner.
3.3. TBARS Assay and Visual Comparison of Serum Trans-
parency. The lipid peroxidation induced by oxidizing agents
is indicated by the production of MDA that ultimately
binds with TBA to produce TBARS. Furthermore, MDA
production is known to be a marker of the serum oxidative
lipid levels, and the color of the end product of the reaction
depends on the amount of lipid present in the serum.
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Table 3: Body weight, diet intake, and liver weight.
Normal diet HFD CJF 100 CJF 400 CJF 800
Body weight (g)
Initial 253.3 ± 7.4 254 ± 8.7 252.6 ± 7.2 250.6 ± 4.7 254 ± 7.9
Final 412 ± 22.5 415.8 ± 15.7 412.6 ± 13 393.9 ± 22.6 391 ± 23.7∗,†
Diet intake (g) 19.87 ± 7.24 20.78 ± 3.04 20.38 ± 3.38 19.49 ± 4.35∗ 19.4 ± 3.81∗
Liver weight (g) 14.09 ± 1.79 14.46 ± 1.05 14.06 ± 1.69 14.01 ± 1.48 12.69 ± 2.15
CJF 100:Wistar rat treated with CJF extract at 100mg⋅kg−1⋅day−1; CJF 400:Wistar rat treated with CJF extract at 400mg⋅kg−1⋅day−1; CJF 800:Wistar rat treated
with CJF extract at mg⋅kg−1⋅day−1. Values are expressed as mean ± SE (standard error), 𝑛 = 8; †𝑃 < 0.05 (versus normal diet) and ∗𝑃 < 0.05 (versus high fat
diet). HFD: high fat diet.
Table 4: Serum lipid profile.
Normal diet HFD CJF 100 CJF 400 CJF 800
Values (mg/dL)
Total cholesterol 64.03 ± 6.46 151.32 ± 17.91 119.42 ± 14.5† 98.57 ± 9.18∗,† 63.97 ± 6.21∗
Triglyceride 86.23 ± 26.21 187.69 ± 22.59 153.73 ± 45.25† 113.92 ± 47.2∗ 82.75 ± 15.33∗
HDL 37.86 ± 3.59 26.78 ± 3.36 35.83 ± 1.80∗ 38.63 ± 6.29∗ 47.88 ± 7.98∗,†
LDL 8.92 ± 10.35 86.12 ± 19.51 53.03 ± 12.38∗,† 38.62 ± 13.2† 3.61 ± 6.92∗
CJF 100:Wistar rat treated with CJF extract at 100mg⋅kg−1⋅day−1; CJF 400:Wistar rat treated with CJF extract at 400mg⋅kg−1⋅day−1; CJF 800:Wistar rat treated
with CJF extract at 800mg⋅kg−1⋅day−1. Values are expressed as mean ± SE (standard error), 𝑛 = 8; †𝑃 < 0.05 (versus normal diet) and ∗𝑃 < 0.05 (versus high
fat diet). HFD: high fat diet.
The result shows that treatment with CJF dose-dependently
decreased subsequent formation of TBARS and the serum
lipid accumulation (Figures 1(a) and 1(b), resp.).
3.4. ORO Staining of Arteries. Figure 2 shows the effect of
CJF on lipid accumulation in the arteries ofWistar rats. ORO
stains the accumulated lipid in the inner layer of arteries with
a dark red color and light red background. The arteries from
the rats fed a normal diet showed negligible ORO staining
while those on the HFD showed a significant ORO-positive
staining. Therefore, treatment with CJF dose-dependently
inhibited the lipid accumulation in the arteries.
4. Discussion
The present study demonstrated that the CJF ameliorated the
discrepancies in the lipid profile of the HFD animal model
by lowering the serum TC, TG, and LDL while increasing
serum HDL. Moreover, the administration of CJF inhibited
the lipid accumulation in the inner layer of the arteries and
lipid peroxidation. Although previous studies have explored
the pharmacological activity of C. japonica leaves and seeds,
there are very few studies reporting the beneficial effects of
its fruit, especially the cardiovascular actions. Therefore, our
finding supports the notion that CJF could be a novel herbal
source of potential drug therapies to target diseases associated
with abnormal lipid metabolism.
HFD-induced hypercholesterolemic rats are used as an
in vivo model for studying cholesterol metabolism [24, 25].
The rat model of obesity or hypercholesterolemia induced
by a HFD simulates the human obesity syndrome, enabling
long-term characterization [26]. Our previous study reported
the vascular protective effect of the ethanolic extract of CJF
via endothelium-dependent relaxation of porcine coronary
arteries and inhibition of vascular smooth muscle cell migra-
tion [18]. In this study, we used a HFD to induce hyperc-
holesterolemia in Wistar rats to evaluate the antiatherogenic
activity of CJF. It is well established that hypercholesterolemia
leads to the progression of various metabolic syndromes
such as atherosclerosis, diabetes mellitus, and hypertension
[27, 28]. In addition, previous studies have reported that the
accumulation of blood lipids, particularly LDL, enhances the
production of reactive oxygen species (ROS). Furthermore,
ROS-induced oxidative stress plays an important role, at least
in part, in the etiology of atherosclerosis and coronary heart
disease [29, 30]. In our experimental model, the rats fed
the HFD for 4 weeks did not show body weight difference
compared to the normal diet. This observation suggests that
the short duration of feeding with the HFDwas not sufficient
to induce obesity as previously reported [5, 31]. However, a
HFD administered for 4 weeks successfully induced hyperc-
holesterolemia in theWistar rats as evidenced by the increase
in serum TC and TG and decrease in serum HDL levels.
Treatment with CJF for 1 month significantly reversed the
abnormal cholesterolmetabolism andmaintained theTC and
TG at levels that were comparable to those of the normal
group rats (fed a standard diet). It is worth noting that CJF
treatment at doses of 400 and 800mg⋅kg−1⋅day−1 decreased
the rat body weight compared to that of the control group
rats fed with the HFD. This dose of CJF is within the safe
dose obtained in a preliminary in vivo toxicity study and,
therefore, indicates that the CJF could be used for its potential
antiobesity effects.
The accumulated serum LDL can easily undergo oxi-
dation by ROS. The oxidative products are then engulfed
by macrophages in the tunica intima of the blood vessels
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Figure 1: Effect of Camellia japonica fruits extract (CJF) on serum lipid peroxidation. (a) Measurement of thiobarbituric acid reactive
substance (TBARS) level was done by comparison with the standard curve obtained using various dilutions of malondialdehyde (MDA).
Values are expressed as mean ± SE (standard error), 𝑛 = 8. †𝑃 < 0.05 (versus normal diet); ∗
𝑃
< 0.05 (versus high fat diet). HFD: high fat
diet. (b) Difference in transparency of serum in each group. After centrifuge of rat blood, compared to normal diet group with transparent
serum, rats fed with HFD show turbid serum due to the presence of high amount of lipid. In case of CJF-treated group, serum of rats treated
with CJF 400 and CJF 800 shows clearly low turbidity with respect to HFD and their transparency is almost similar to normal diet group.
Normal diet High fat diet
CJF 800mg/kgCJF 400mg/kgCJF 100mg/kg
Figure 2: Histological analysis of oil red O staining of the rat’s artery. The figure shows the photograph of ORO stained artery of Wistar rats.
Scale bar beneath the artery represents the actual length of each artery. Arrow head indicates the red positive stain of ORO dye of the lipid
accumulated on the vessel wall.
and are subsequently converted into fatty streak foam cells
that facilitate atherogenesis [32]. The results of the TBARS
assay suggest that the CJF markedly inhibited the serum
lipid peroxidation, which likely attenuated one of the crucial
steps in atherogenesis. It is widely accepted that vascular
homeostasis is maintained by a balanced ratio of NO and
endothelin-1 (ET-1) [33]. An imbalance in NO and ET-
1 results in vascular endothelial dysfunction, leading to
vascular inflammation and atherosclerotic plaque formation.
The function of NO depends on its level and origin. Under
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normal conditions, the NO produced by endothelial cells via
endothelial NO synthase (eNOS) acts as a potent vasodila-
tor and inhibits vascular smooth muscle cell proliferation,
platelet aggregation, and leukocyte adhesion [34]. In contrast,
excessive NO can generate potent oxidizing peroxynitrite
anions (ONOO−), which react with superoxide anions to
induce lipid peroxidation and endothelial dysfunction. In
our previous study, CJF significantly upregulated eNOS
phosphorylation in primary endothelial cells extracted from
porcine coronary arteries [18]. In contrast, CJF significantly
inhibited the lipid peroxidation, suggesting that it exhibited
cardiovascular protective effects in this study.
During hypercholesterolemia, lipids accumulate on the
inner layer of the blood vessel walls as the primary step in
atherogenesis.There is a direct correlation between increased
serum lipids, especially cholesterol, LDL, and other lipopro-
tein particles and the accumulation of lipids within the
arterial wall, leading to atherosclerotic plaque development
[35]. However, a high level of plasma HDL is protective
against plaque formation because of its role in reverse choles-
terol transport (RCT) and antiatherogenic properties [36].
A recent study indicated that high plasma HDL cholesterol
levels are not solely responsible for the antiatherogenic role
of HDL, but the ability of HDL to efflux the cholesterol
underlies its role in RCT [37].The result of our ORO staining
revealed that administration of CJF to HFD-fed Wistar
rats decreased the ORO-positive staining, which indicates
the level of lipid accumulation on the artery inner layer,
compared to control group (fed with HFD and untreated).
Similarly, the serumHDL levels also increased.The diagnosis
of hyperlipidemia by visual inspection of separated serum is
often hindered by turbid serum samples due to an abnormally
high accumulation of blood lipids [38]. Our results revealed
that the separated serum of the HFD-fed rats showed very
high turbidity compared to that of the rats fed with a normal
diet. However, treatment with the CJF lowered the serum
turbidity likely because of the decreased accumulation of
blood lipids. There are numerous steps involved in lipid
metabolism under both pathological and pathophysiological
conditions. Our data suggest that CJF played a crucial role
in restoring the balance of the abnormal lipid metabolism
by selectively reducing the unhealthy lipids (LDL, TG, and
cholesterol). In contrast, the extract increased the HDL
content of the blood, which inhibited lipid peroxidation. The
potential mechanism underlying the actions of the CJF could
be the attenuation of the early phase of atherosclerosis and
dyslipidemia, in part, due to its high polyphenol and tannin
content as previously reported [39]. However, the exact
underlying mechanism of CJF should be investigated further.
Collectively, our results provide clear evidence that the CJF
possess potential therapeutic hypercholesterolemia-lowering
effects, which could prevent atherogenesis. Overall, CJF
modulated cholesterol metabolism by lowering the serum
TG, LDL, and TC while increasing the beneficial cholesterol
(HDL).
C. japonica is a popular garden plant in East Asia, and
its different parts including the flower, seed, and leaves are
currently used as traditional medicines and commercialized
as a source of cosmetics. Previous studies have indicated that
the extracts of different parts of theC. japonica plant have var-
ious biological activities. It has been reported that extracts of
C. japonica flowers possess antioxidant effects via scavenging
of ROS and induction of antioxidant enzymes [40]. Extracts
of C. japonica leaves have shown antihuman HIV activity by
inhibiting the HIV-protease enzyme, which is required for
cleaving newly synthesized polyproteins essential for virion
maturity [14]. In addition, it exhibits antioxidant activity
via free radical scavenging potency mainly due to the pres-
ence of tannins [15], antiphotoaging capability by reducing
the carbonylation of tape-stripped stratum corneum after
ultraviolet B (UVB) irradiation, and decreasing intracellular
ROS generation in HaCaT keratinocytes [16]. Furthermore,
its hypotriglyceridemic activity is mediated by decreasing
serum and hepatic triglyceride level as well as lowering
lipogenic enzymes activity in the liver [17]. The studies of
the biological activities of C. japonica have been focused
on the seeds, flowers, and leaves, but not the fruits. The
constituents of C. japonica such as saponins in the seeds [41],
flavonol glycosides in the leaves [42, 43], and triterpenes,
several hydrolyzable tannins, acylated anthocyanins, and
purine alkaloids in the flowers [44] have been reported.
The present findings suggest that the fruit of C. japonica
has strong cardiovascular protective effects and could be a
good potential candidate for development as a natural-based
medicine for the prevention and treatment of cardiovascular
diseases. Despite these beneficial effects of the fruit, there is
very little information available on its constituents compared
with the seeds and leaves. Recently, Uddin et al. isolated
oleanane-type triterpenes from the fruit peels of C. japonica,
which inhibited protein tyrosine phosphatase 1B [39]. There-
fore, the characterization of the chemical constituents and
elucidation of the active compounds from CJF are currently
being conducted by our research team.
5. Conclusion
In this study, we demonstrated the antiatherogenic activity
of CJF mediated by the lowering of the serum TC and
TG and increasing the serum HDL. Similarly, CJF inhibited
the lipid accumulation on the inner blood vessel walls and
significantly decreased lipid peroxidation, thereby provid-
ing evidence of its efficacy in reducing the progression of
atherosclerosis. Taken together, these results suggest that CJF
could be a potential herbal therapeutic option for lowering
hypercholesterolemia and preventing atherosclerosis pro-
gression triggered by abnormal lipid metabolism. However,
further studies are necessary to identify the active phyto-
chemicals in CJF and elucidate their underlying vascular
protective mechanisms.
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